Home Stock

Stock Research: Bio-Techne

Independent, rules-based stock research to judge this stock's true performance: Cut through market noise and find high-growth or high-value gems from 8,000+ stocks worldwide.

Bio-Techne

NSQ:TECH US09073M1045
93
  • Value
    82
  • Growth
    24
  • Safety
    Safety
    100
  • Combined
    86
  • Sentiment
    57
  • 360° View
    360° View
    93
Unlock
What factors are driving this 360° View?
Subscribe to View
Company Description

Bio-Techne Corporation is a global life sciences company providing tools and reagents for research and diagnostics. It operates in the life sciences industry with segments including Protein Sciences and Diagnostics and Genomics. In the last fiscal year, the company had a market cap of $8,149 million, profits of $770 million, and revenue of $1,159 million, with 3,100 employees.

more

ANALYSIS: With an Obermatt 360° View of 93 (better than 93% compared with alternatives) for 2026, overall professional sentiment and financial characteristics for the stock Bio-Techne are very positive. The 360° View is based on consolidating four consolidated indicators, with half of the indicators below and half above average for Bio-Techne. The consolidated Value Rank has an attractive rank of 82, which means that the share price of Bio-Techne is on the lower side compared with typical size in indicators such as revenues, profits, and invested capital. This means the stock price is lower than for 82% of alternative stocks in the same industry. The company is also safely financed with a Safety rank of 100. In addition, professional market sentiment is above average compared with other stock investment alternatives with a Sentiment Rank of 57. But the consolidated Growth Rank has a low rank of 24, which means that the company is below average in terms of growth and momentum when looking at financial metrics such as revenue, profit, and invested capital growth as well as stock returns. 76 of its competitors have better growth. ...read more

more
Strongest Rank Price vs. Earnings (P/E)
Weakest Rank Safety
Country USA
Industry Life Sciences Tools & Services
Size Large
Website bio-techne.com
Index
NASDAQ
D.J. US Health Care
S&P 500
Bio-Techne stock price by TradingView. Not sourced by Obermatt.
Similar Add to Watchlist Similar See Similar Stocks
The higher the 360° View, the better the stock performed against its peers, considering all metrics. The 360° View represents an average of the other 5 ranks and is then scaled to a rank from 1 to 100. The shaded values are illustrative only.
Last update: 13-Mar-2026.

Make Sense of the Ranks

The higher, the better. For every stock, we judge its performance against its peers and rank it on a scale of 1 to 100. These ranks are percentiles: a rank of 75 means the company outperforms 75% of its peers in that specific area. The higher the rank, the better the stock stacks up against its peers.

Value
Identifies how good a value the stock is.
Good Value Expensive
Combined
Consolidated view across Value, Growth, and Safety.
Good Tread Carefully
Growth
Shows a company's growth potential.
High Growth Tough Times
Sentiment
Shows what the market thinks of a stock.
Positive Sentiment Skepticism
Safety
Safety
Assesses how financially secure a company is.
Well-Financed High Leverage
360° View
360° View
Holistic stock analysis: all key non-/financial metrics
Good Watch Out

Detailed and Historical Ranks

Deep dive into 15 detailed ranks and 3 years of history. Unlock the analysis.

Unlock Ranks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Value
82 66 52 67
Growth
24 73 49 71
Safety
Safety
100 85 52 51
Sentiment
57 98 92 97
360° View
360° View
93 100 81 97
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Analyst Opinions
33 49 95 83
Opinions Change
50 85 50 50
Pro Holdings
n/a 90 53 91
Market Pulse
48 93 85 56
Sentiment
57 98 92 97
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Value
82 66 52 67
Growth
24 73 49 71
Safety Safety
100 85 52 51
Combined
86 100 55 86
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Price vs. Sales (P/S)
50 19 15 27
Price vs. Earnings (P/E)
14 32 27 20
Price vs. Book (P/B)
38 34 27 20
Dividend Yield
97 96 96 98
Value
82 66 52 67
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Revenue Growth
30 54 58 41
Profit Growth
94 53 42 49
Capital Growth
20 68 39 67
Stock Returns
26 65 49 67
Growth
24 73 49 71
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Leverage
51 56 47 44
Refinancing
92 20 7 15
Liquidity
97 94 87 78
Safety Safety
100 85 52 51

Similar Stocks

Discover high‑ranked alternatives to Bio-Techne and broaden your portfolio horizons.

Zimmer

NYQ:ZBH
Country: USA
Industry: Health Care Equipment
Size: X-Large
Full Stock Analysis

M/I Homes

NYQ:MHO
Country: USA
Industry: Homebuilding
Size: Medium
Full Stock Analysis

Revvity

NYQ:RVTY
Country: USA
Industry: Life Sciences Tools & Services
Size: Large
Full Stock Analysis

FedEx

NYQ:FDX
Country: USA
Industry: Air Freight & Logistics
Size: XX-Large
Full Stock Analysis

Frequently Asked
Questions

The stock offers good value, safe financing, and positive sentiment. However, it has below-average growth expectations. It is well-suited for conservative buy-and-hold investors who prioritize stability and low valuation over growth.

Obermatt provides unbiased stock analysis as a completely independent third party. We have no conflicts of interest with individual stock titles. Our data-driven analysis is based on algorithms honed over twelve years, giving you analysis that is free from personal bias and conflicts of interest.

The 360° View Rank indicates a company's overall performance across all major financial and non-financial metrics tracked by Obermatt. A 360° View Rank of 75 means the company is more well-rounded than 75% of similar companies. A high score indicates that the company is strong across the board; it is attractively priced, growing sustainably, financially stable, and well-regarded by the market. Learn more.

Become an Obermatt subscriber and see all of the similar stocks here.

OTHER FEATURES

Use the Platform to its Fullest

The Obermatt Advantage

Ready to Elevate Your Investing?
Get Started Today

Choose the Obermatt subscription that best fits your needs.


30-day money back guarantee. Your subscription will renew until you cancel it, which you can do at any time.

What Our Customers Say

See how Obermatt improved their investing:

Review us See More Google Reviews